Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer
about
Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease ProgressionMaraviroc: a review of its use in HIV infection and beyondEchinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infectionRelationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials studyDiscovering disease associations by integrating electronic clinical data and medical literatureInitiation of antiretroviral therapy.Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review.Application of a high-throughput fluorescent acetyltransferase assay to identify inhibitors of homocitrate synthasePriorities for screening and treatment of latent tuberculosis infection in the United StatesImportance of nonenteric protozoan infections in immunocompromised people.Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South AfricaConsiderations when prescribing trimethoprim-sulfamethoxazole.Fatal varicella due to the vaccine-strain varicella-zoster virus.Quantiferon Gold-in-tube assay for TB screening in HIV infected children: influence of quantitative values.Microsporidiosis acquired through solid organ transplantation: a public health investigationTrends in hospitalizations among children and young adults with perinatally acquired HIV.Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective studyAntimicrobial susceptibility patterns of enterobacteriaceae isolated from HIV-infected patients in KinshasaSerum peak sulfamethoxazole concentrations demonstrate difficulty in achieving a target range: a retrospective cohort study.A case-control study of risk factors for HIV-negative children with cryptococcal meningitis in Shi Jiazhuang, China.Rate of candidiasis among HIV-infected children in Spain in the era of highly active antiretroviral therapy (1997-2008).Pet husbandry and infection control practices related to zoonotic disease risks in Ontario, Canada.Age at cancer diagnosis among persons with AIDS in the United States.Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals.Synthesis and antifungal activity of functionalized 2,3-spirostane isomersComorbidities in children and adolescents with AIDS acquired by HIV vertical transmission in Vitória, BrazilImpaired humoral response to vaccines among HIV-exposed uninfected infantsTime trends of baseline demographics and clinical characteristics of HIV infected children enrolled in care and treatment service in Dar es Salaam, Tanzania.Effect of highly active antiretroviral therapy on vaginal Candida spp. isolation in HIV-infected compared to HIV-uninfected womenOutcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency.Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis.Procedures for collection of induced sputum specimens from children.Long-term cancer risk among people diagnosed with AIDS during childhoodHospital admissions from a pediatric HIV care and treatment program in Malawi.Tuberculous meningitis: diagnosis and treatment overview.Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation.Understanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings.First Report of Ventriculoperitoneal Shunt Infection due to Cyberlindnera fabianiiUp-regulation of TLR2 and TLR4 in dendritic cells in response to HIV type 1 and coinfection with opportunistic pathogensShort communication: factors influencing time to CD4(+) T cell counts >200 cells/mm(3) in HIV-infected individuals with CD4(+) T cell <50 cells/mm(3) at the time of starting combination antiretroviral therapy
P2860
Q26751304-5BE47DBF-792E-4CFB-BF72-189F45116DE1Q26778504-8B662E15-5773-4E5F-BA88-C179699F79B0Q28472713-D0451C43-E976-412B-BE57-E500E3241B0BQ28475281-E57B0360-2B8A-42AC-8869-B13FB8F2A272Q28743290-8CAE0878-D0DE-4D52-A305-3E729A682B44Q30209635-061400CD-B502-43C0-BB98-72C3079B888AQ33590896-90F5D1CB-6923-4D19-91E7-DE2F60EB685EQ33745848-24138974-3A33-45A0-A561-7EE8EDACD700Q33895875-8D498E18-FA6D-4AF2-8AAF-51527B016D1AQ34189873-F176449C-BC50-41C1-AE3D-4AEFCA1EF086Q34209707-EF2255BC-74D7-4A6D-A5D2-F6516CF5D5E2Q34223201-7DA0BFC0-6DB5-47C0-B957-4E7AF77B2FD7Q34271522-8C43F4AA-DCE0-42FC-9B92-A0171593DE92Q34274010-E35E3EC2-EA23-4688-B85E-1DA08A9FDC1BQ34414950-C3AFC7BC-0561-4F3A-9592-F85B44DC299BQ34432664-4CA2EB40-2FE0-4CA7-920F-E39AD3FED476Q34445856-2B1937A0-322A-4AF9-AEEA-07CCB935BA84Q34476132-22453E98-791D-42DB-8DE5-2DDCCDBD771BQ34498991-6B08E602-11AE-468E-8432-71B776C6E8F7Q34522791-B6A5F1B0-FC82-43B2-9CA4-FBB56E82D584Q34627658-E802F52D-96A7-4A97-AAF3-83E174D15506Q34743277-56E2B895-30FF-47EE-B843-54654AE0D76AQ34766695-15D544FB-E7D7-4F55-BD6D-5FF70695CCC6Q34831090-C20A7AB3-AAE2-4B13-9834-AAE1A192CCC5Q34953266-7E7FDADD-A27D-493E-9A4E-BF169C6A5E31Q35064073-281C7166-8F49-48EE-A999-88EE3F5F6BF7Q35191100-A0ABE03A-E2A7-42C1-988D-571C501DC667Q35233180-224DEBC7-12F9-47F2-8773-AB00D86276BBQ35617437-CCF6E061-A024-4589-A65D-4EE80FDF635FQ35629437-5AAD5D75-4F96-4C43-B86D-A20CC3F79880Q35690978-9BA2E9F3-428A-498F-8FCF-E8653EC6F598Q35815078-5C25489B-BC64-4C07-ACDD-E2895A93D4AFQ35851884-3FDD9D93-976D-477D-B810-7F9AF2A4AC3DQ35910124-823D2283-2E6B-4AA8-ABB6-4349C330A79CQ35910242-AE1A4260-4BAB-4398-AD32-6DBC5F79787CQ36250895-A1D56FA2-F1E5-4C3F-A2EF-DB728E67381DQ36288227-B10B3285-F1B8-4F5D-BA61-1C29F896AFCBQ36290299-B68384B1-FAA3-422B-AD94-9FCA45224C25Q36352579-AD3C2CA9-CA7B-4B56-A056-62D02E697D1EQ36419507-78907288-2706-4387-A37C-CA52E4EB866D
P2860
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Guidelines for the Prevention ...... tious Diseases Society of Amer
@ast
Guidelines for the Prevention ...... tious Diseases Society of Amer
@en
type
label
Guidelines for the Prevention ...... tious Diseases Society of Amer
@ast
Guidelines for the Prevention ...... tious Diseases Society of Amer
@en
prefLabel
Guidelines for the Prevention ...... tious Diseases Society of Amer
@ast
Guidelines for the Prevention ...... tious Diseases Society of Amer
@en
P2093
P2860
P50
P1476
Guidelines for the Prevention ...... tious Diseases Society of Amer
@en
P2093
Edward Handelsman
HIV Medicine Association of the Infectious Diseases Society of America
Jennifer S Read
Kenneth L Dominguez
Leslie Serchuck
Lynne M Mofenson
Michael T Brady
Peter Havens
Rohan Hazra
Russell Van Dyke
P2860
P50
P577
2009-09-01T00:00:00Z